Navigation Links
The Carpal Solution

ProductsThe Carpal Solution
Company First Hand Medical
Item The Carpal Solution
Features 
  • The Carpal Solution gently tugs simultaneously at three key points on the palm surrounding the carpal tunnel during sleep. Consistent gentle pulling action applied for 6 to 8 hours while the hand is relaxed, decompresses and reshapes the soft tissue around the carpal tunnel relieving pressure on the Median Nerve.
  • Carpal Solution combines this patented gentle soft tissue reshaping method during sleep with active use during the day. This results in an ideal rhythmic therapy for rapid relief from Carpal Tunnel Syndrome symptoms with no muscle atrophy or down time. The hand rehabilitates through normal use once pain is relieved.
  • The Carpal Solution has been shown to enhance blood circulation to the hand. Dr. Morgan suggests that increased nutrient and oxygen rich blood circulation reinvigorates the hand naturally and helps contribute to rapid recovery.
  • The Carpal Solution is specially designed to have an elasticity which matches the same basic elasticity found in ones skin, muscles and connective fascia tissue, allowing it to work in harmony with the bodys natural ability to stretch and relieve unwanted pressure and allow improved circulation in and around the Carpal Tunnel.
Description The Carpal Solution offers relief from CTS pain and hand tingling in days. It is different from other over-the-counter CTS treatments. It is not a rigid immobilizing brace. Worn during sleep, the Carpal Solution gently reshapes soft tissue in and around the Carpal Tunnel and eliminates hand pain, numbness and sleep interruption. It allows people to get back to their active life styles.
Info First Hand Medical
Customer Service: (781) 418-6340
Web site: http://www.mycarpaltunnel.com

Related medicine products :

1. Endoscopic Carpal Tunnel Release System
2. The Endotrac™ System For Endoscopic Carpal Tunnel Releases (ECTR)
3. Diamond Carpal Fusion Plates with System Pack Technology
4. Swanson Titanium Carpal Lunate Implants
5. Swanson Titanium Carpal Scaphoid Implant
6. MicroAire Carpal Tunnel Release System
7. ReNu MultiPlus Multi-Purpose Solution
8. Renu Multi-Purpose Solution
9. Opti-One Multi-Purpose Solution
10. Solo-Care Brand Multipurpose Solution
11. Sensitive Eyes Plus Saline Solution
(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: